Revlimid, Eliquis and Eylea top Medicare spending ranks by Eric Sagonowsky Friday, March 15, 2019 CMS has rolled out data to show which drugs dominated the most federal spending in 2017 and how their pricing changed from prior years
Pfizer lowers RA patients' Xeljanz dose on safety concerns by Eric Sagonowsky Wednesday, February 20, 2019 Pfizer moved rheumatoid arthritis patients to a lower Xeljanz dose after a data monitoring board highlighted safety concerns for the 10-mg arm.
Top 10 drugs losing exclusivity in 2019 by Eric Sagonowsky Pharma companies do their best to fight off patent expirations and generic competition as long as possible to protect their big moneymakers. But this year looks like the end of the line for many of the industry's top brands.
PBM giant says 2018 drug cost growth was lowest in 25 years by Eric Sagonowsky Friday, February 8, 2019 Top PBM Express Scripts said that its efforts saved clients $45 billion in 2018, and its clients' drug costs grew just 0.4% last year.
Pharma's DTC TV spending soars to $3.7B in 2018 by Beth Snyder Bulik Wednesday, January 2, 2019 TV spending on pharma ads continued to rise in 2018, topping $3.73 billion in national TV ad spending, according to data from TV ad tracker iSpot.tv.
Pfizer wins blockbuster patent extension for Lyrica by Eric Sagonowsky Wednesday, November 28, 2018 Pfizer's top drug Lyrica will get another 6 months of protected sales after the FDA granted the drug a pediatric exclusivity extension.
U.K. Supreme Court rejects Pfizer's Lyrica patent appeal by Eric Sagonowsky Wednesday, November 14, 2018 Pfizer has come up short in a long-running patent battle in the U.K. over its blockbuster Lyrica, potentially costing the drugmaker.
Big TV spender Lyrica drops off top 10 in October by Beth Snyder Bulik Monday, November 5, 2018 Is Pfizer’s Lyrica leaving the TV ad game? Facing patent expiration, the stalwart top 10 TV spender dropped its budget to $3.8 million in October.
Pharma TV ad spend beats last year, led by AbbVie and Pfizer by Beth Snyder Bulik Monday, October 15, 2018 With three quarters of pharma TV ad spending down and one to go, national media buys are tracking ahead of 2017, with brands doling out $2.81 billion.
